In an in vitro diagnostic test for osteoarthritis or rheumatoid arthritis,
the amount or presence in a sample of anisomerised or optically inverted
protein fragment is measured which derives from perlecan, bigylcan,
decorin, fibrillin-1 or protocadherin or which is a specific sequence
from aggrecan, type II collagen, COMP or CILP.